 Francesca Cendali
Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glucosephosphate Dehydrogenase | 3 | 2025 | 60 | 1.160 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 2 | 2025 | 32 | 1.130 |
Why?
| | Anemia, Sickle Cell | 5 | 2025 | 270 | 0.820 |
Why?
| | Exercise Tolerance | 1 | 2025 | 279 | 0.790 |
Why?
| | Physical Conditioning, Animal | 1 | 2025 | 257 | 0.760 |
Why?
| | Erythrocytes | 8 | 2025 | 700 | 0.670 |
Why?
| | beta-Thalassemia | 3 | 2025 | 36 | 0.610 |
Why?
| | Metabolome | 4 | 2025 | 350 | 0.510 |
Why?
| | Hemolysis | 4 | 2025 | 206 | 0.490 |
Why?
| | Proteome | 4 | 2025 | 472 | 0.460 |
Why?
| | Metabolomics | 7 | 2025 | 678 | 0.360 |
Why?
| | Disease Models, Animal | 7 | 2025 | 4295 | 0.340 |
Why?
| | Proteomics | 6 | 2025 | 1111 | 0.300 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2023 | 801 | 0.270 |
Why?
| | Maple Syrup Urine Disease | 1 | 2025 | 5 | 0.240 |
Why?
| | Transcriptome | 2 | 2022 | 971 | 0.240 |
Why?
| | Primaquine | 1 | 2024 | 7 | 0.230 |
Why?
| | Hemopexin | 1 | 2025 | 27 | 0.230 |
Why?
| | Blood Coagulation Disorders | 2 | 2023 | 173 | 0.220 |
Why?
| | Heme | 1 | 2025 | 78 | 0.220 |
Why?
| | Connective Tissue Diseases | 1 | 2025 | 84 | 0.220 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2024 | 108 | 0.220 |
Why?
| | Hemoglobin SC Disease | 1 | 2023 | 13 | 0.210 |
Why?
| | Balloon Occlusion | 1 | 2024 | 34 | 0.210 |
Why?
| | Oxidative Stress | 3 | 2025 | 1317 | 0.210 |
Why?
| | Blood Preservation | 3 | 2022 | 285 | 0.210 |
Why?
| | Sickle Cell Trait | 1 | 2023 | 13 | 0.200 |
Why?
| | Multiple Trauma | 1 | 2024 | 100 | 0.200 |
Why?
| | Tranexamic Acid | 1 | 2023 | 40 | 0.200 |
Why?
| | Antifibrinolytic Agents | 1 | 2023 | 51 | 0.200 |
Why?
| | Viral Nonstructural Proteins | 1 | 2023 | 65 | 0.200 |
Why?
| | Spleen | 1 | 2025 | 514 | 0.200 |
Why?
| | Iron | 1 | 2025 | 313 | 0.190 |
Why?
| | Amino Acid Transport System y+ | 1 | 2022 | 9 | 0.190 |
Why?
| | Sertoli Cells | 1 | 2022 | 26 | 0.190 |
Why?
| | Fibrinolysis | 1 | 2023 | 146 | 0.190 |
Why?
| | Pulmonary Artery | 2 | 2025 | 1086 | 0.190 |
Why?
| | Ribosomes | 1 | 2023 | 186 | 0.190 |
Why?
| | Athletic Performance | 1 | 2023 | 79 | 0.190 |
Why?
| | Cardiopulmonary Bypass | 1 | 2024 | 209 | 0.190 |
Why?
| | Rejuvenation | 1 | 2022 | 19 | 0.190 |
Why?
| | Polyamines | 1 | 2022 | 40 | 0.190 |
Why?
| | Lung | 2 | 2025 | 4060 | 0.180 |
Why?
| | Aurora Kinase B | 1 | 2021 | 8 | 0.180 |
Why?
| | Blood | 1 | 2022 | 107 | 0.180 |
Why?
| | Mice | 8 | 2025 | 17787 | 0.180 |
Why?
| | Shock, Hemorrhagic | 1 | 2023 | 167 | 0.180 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2021 | 65 | 0.170 |
Why?
| | Fatty Acid Desaturases | 1 | 2021 | 32 | 0.170 |
Why?
| | Protein Biosynthesis | 1 | 2023 | 433 | 0.170 |
Why?
| | Animals | 12 | 2025 | 36940 | 0.170 |
Why?
| | Aniline Compounds | 1 | 2021 | 102 | 0.170 |
Why?
| | Immunotherapy, Adoptive | 1 | 2024 | 327 | 0.170 |
Why?
| | Interferons | 1 | 2022 | 202 | 0.170 |
Why?
| | Androgens | 1 | 2022 | 187 | 0.170 |
Why?
| | Pyrazines | 1 | 2021 | 90 | 0.170 |
Why?
| | Membrane Lipids | 1 | 2021 | 91 | 0.170 |
Why?
| | Host-Pathogen Interactions | 1 | 2023 | 364 | 0.170 |
Why?
| | Databases, Genetic | 1 | 2021 | 237 | 0.160 |
Why?
| | Physical Exertion | 1 | 2021 | 215 | 0.160 |
Why?
| | Mice, Transgenic | 1 | 2025 | 2167 | 0.160 |
Why?
| | Hemorrhage | 1 | 2023 | 722 | 0.150 |
Why?
| | Humans | 24 | 2025 | 137585 | 0.140 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2024 | 900 | 0.140 |
Why?
| | Mitochondria | 1 | 2024 | 948 | 0.140 |
Why?
| | Liver Transplantation | 1 | 2025 | 871 | 0.140 |
Why?
| | Tumor Microenvironment | 1 | 2021 | 674 | 0.130 |
Why?
| | Swine | 3 | 2024 | 775 | 0.130 |
Why?
| | Oxygen | 1 | 2022 | 931 | 0.130 |
Why?
| | Hypertension, Pulmonary | 2 | 2025 | 1910 | 0.130 |
Why?
| | Liver | 1 | 2025 | 1943 | 0.120 |
Why?
| | Exercise | 3 | 2025 | 2057 | 0.120 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2021 | 1396 | 0.120 |
Why?
| | Muscle, Skeletal | 1 | 2025 | 1724 | 0.110 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2021 | 630 | 0.110 |
Why?
| | Biomarkers, Tumor | 1 | 2021 | 1276 | 0.110 |
Why?
| | Anti-HIV Agents | 1 | 2020 | 778 | 0.110 |
Why?
| | Hemoglobin, Sickle | 2 | 2023 | 19 | 0.100 |
Why?
| | Prognosis | 1 | 2021 | 4030 | 0.100 |
Why?
| | Kynurenine | 2 | 2023 | 114 | 0.090 |
Why?
| | Blood Coagulation | 2 | 2024 | 255 | 0.090 |
Why?
| | Datasets as Topic | 2 | 2022 | 121 | 0.090 |
Why?
| | Breast Neoplasms | 1 | 2023 | 2253 | 0.090 |
Why?
| | Male | 11 | 2025 | 67762 | 0.090 |
Why?
| | Mice, Inbred C57BL | 3 | 2025 | 5757 | 0.080 |
Why?
| | Homeostasis | 2 | 2023 | 621 | 0.080 |
Why?
| | Amino Acids | 2 | 2023 | 497 | 0.070 |
Why?
| | Cell Line, Tumor | 2 | 2024 | 3412 | 0.060 |
Why?
| | HIV Infections | 1 | 2020 | 2836 | 0.060 |
Why?
| | Amino Acids, Branched-Chain | 1 | 2025 | 36 | 0.060 |
Why?
| | Heme Oxygenase-1 | 1 | 2025 | 64 | 0.060 |
Why?
| | RNA, Messenger | 2 | 2023 | 2833 | 0.060 |
Why?
| | Antimalarials | 1 | 2024 | 31 | 0.060 |
Why?
| | Diethylhexyl Phthalate | 1 | 2024 | 15 | 0.050 |
Why?
| | Cell Respiration | 1 | 2024 | 103 | 0.050 |
Why?
| | Plastics | 1 | 2024 | 42 | 0.050 |
Why?
| | Ovalbumin | 1 | 2024 | 183 | 0.050 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2024 | 145 | 0.050 |
Why?
| | Aerosols | 1 | 2025 | 176 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2022 | 3556 | 0.050 |
Why?
| | Female | 7 | 2025 | 73304 | 0.050 |
Why?
| | Hydroxyurea | 1 | 2023 | 35 | 0.050 |
Why?
| | Phthalic Acids | 1 | 2024 | 40 | 0.050 |
Why?
| | Melanoma, Experimental | 1 | 2024 | 114 | 0.050 |
Why?
| | Succinates | 1 | 2023 | 22 | 0.050 |
Why?
| | Pyrroles | 1 | 2024 | 213 | 0.050 |
Why?
| | Injections, Intramuscular | 1 | 2023 | 129 | 0.050 |
Why?
| | Pyruvates | 1 | 2023 | 24 | 0.050 |
Why?
| | Lactates | 1 | 2023 | 85 | 0.050 |
Why?
| | Glycolysis | 1 | 2025 | 321 | 0.050 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2023 | 137 | 0.050 |
Why?
| | Conserved Sequence | 1 | 2023 | 239 | 0.050 |
Why?
| | Vascular Remodeling | 1 | 2024 | 193 | 0.050 |
Why?
| | Random Allocation | 1 | 2023 | 353 | 0.050 |
Why?
| | Leydig Cells | 1 | 2022 | 15 | 0.050 |
Why?
| | Cystine | 1 | 2022 | 18 | 0.050 |
Why?
| | Bile Acids and Salts | 1 | 2023 | 200 | 0.050 |
Why?
| | Bicycling | 1 | 2023 | 114 | 0.050 |
Why?
| | Thrombelastography | 1 | 2023 | 154 | 0.050 |
Why?
| | Glutamates | 1 | 2022 | 59 | 0.050 |
Why?
| | Spermatogenesis | 1 | 2022 | 67 | 0.050 |
Why?
| | Mitochondrial Proteins | 1 | 2024 | 257 | 0.050 |
Why?
| | Sulfur | 1 | 2022 | 58 | 0.050 |
Why?
| | Cardiac Catheterization | 1 | 2025 | 530 | 0.050 |
Why?
| | Testis | 1 | 2022 | 151 | 0.050 |
Why?
| | Luteinizing Hormone | 1 | 2022 | 185 | 0.040 |
Why?
| | Indoles | 1 | 2024 | 412 | 0.040 |
Why?
| | Aorta | 1 | 2024 | 417 | 0.040 |
Why?
| | Erythrocyte Count | 1 | 2021 | 20 | 0.040 |
Why?
| | Access to Information | 1 | 2021 | 49 | 0.040 |
Why?
| | Pyruvic Acid | 1 | 2021 | 53 | 0.040 |
Why?
| | Carnitine | 1 | 2021 | 84 | 0.040 |
Why?
| | Erythrocyte Deformability | 1 | 2021 | 19 | 0.040 |
Why?
| | Purines | 1 | 2022 | 176 | 0.040 |
Why?
| | Cysteine | 1 | 2022 | 204 | 0.040 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2021 | 99 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 558 | 0.040 |
Why?
| | Monocytes | 1 | 2023 | 563 | 0.040 |
Why?
| | Fluorenes | 1 | 2020 | 44 | 0.040 |
Why?
| | Data Mining | 1 | 2021 | 116 | 0.040 |
Why?
| | Sofosbuvir | 1 | 2020 | 62 | 0.040 |
Why?
| | Glutathione | 1 | 2022 | 356 | 0.040 |
Why?
| | Exome | 1 | 2021 | 231 | 0.040 |
Why?
| | Protease Inhibitors | 1 | 2020 | 107 | 0.040 |
Why?
| | Tryptophan | 1 | 2021 | 183 | 0.040 |
Why?
| | Alanine | 1 | 2020 | 152 | 0.040 |
Why?
| | Blood Donors | 1 | 2021 | 105 | 0.040 |
Why?
| | Erythrocyte Transfusion | 1 | 2022 | 194 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1710 | 0.040 |
Why?
| | Benzimidazoles | 1 | 2020 | 170 | 0.040 |
Why?
| | Lactic Acid | 1 | 2021 | 305 | 0.040 |
Why?
| | Neoplastic Stem Cells | 1 | 2023 | 399 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2021 | 955 | 0.040 |
Why?
| | Adult | 4 | 2025 | 37929 | 0.040 |
Why?
| | Lipids | 1 | 2023 | 672 | 0.040 |
Why?
| | Tenofovir | 1 | 2020 | 243 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 1 | 2024 | 2486 | 0.040 |
Why?
| | Adenine | 1 | 2020 | 271 | 0.040 |
Why?
| | Acute Disease | 1 | 2021 | 1007 | 0.040 |
Why?
| | Fatty Acids | 1 | 2021 | 443 | 0.040 |
Why?
| | Cardiac Surgical Procedures | 1 | 2024 | 530 | 0.040 |
Why?
| | Kinetics | 1 | 2022 | 1670 | 0.040 |
Why?
| | Testosterone | 1 | 2022 | 409 | 0.040 |
Why?
| | Oxygen Consumption | 1 | 2021 | 696 | 0.030 |
Why?
| | Inpatients | 1 | 2022 | 500 | 0.030 |
Why?
| | Prevalence | 1 | 2024 | 2734 | 0.030 |
Why?
| | Middle Aged | 3 | 2025 | 33479 | 0.030 |
Why?
| | Machine Learning | 1 | 2021 | 493 | 0.030 |
Why?
| | Rats | 1 | 2024 | 5647 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2757 | 0.030 |
Why?
| | Macrophages | 1 | 2023 | 1547 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2021 | 916 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2022 | 3015 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1774 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2828 | 0.030 |
Why?
| | Body Mass Index | 1 | 2021 | 2389 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2024 | 6079 | 0.020 |
Why?
| | Cohort Studies | 1 | 2021 | 5742 | 0.020 |
Why?
| | Infant | 1 | 2024 | 9465 | 0.020 |
Why?
| | Child, Preschool | 1 | 2024 | 11074 | 0.020 |
Why?
| | Prospective Studies | 1 | 2021 | 7604 | 0.020 |
Why?
| | Aged | 1 | 2025 | 23961 | 0.010 |
Why?
| | Young Adult | 1 | 2021 | 13209 | 0.010 |
Why?
| | Adolescent | 1 | 2024 | 21513 | 0.010 |
Why?
| | Child | 1 | 2024 | 21935 | 0.010 |
Why?
|
|
Cendali's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|